Related Experiment Video

Updated: Aug 7, 2026

Analysis of Cell Cycle Position in Mammalian Cells
12:19

Analysis of Cell Cycle Position in Mammalian Cells

Published on: January 21, 2012

Dual mechanisms for the inhibition of E2F binding to RB by cyclin-dependent kinase-mediated RB phosphorylation

E S Knudsen1, J Y Wang

  • 1Department of Biology and Center for Molecular Genetics, University of California at San Diego, La Jolla 92093-0322, USA.

Molecular and Cellular Biology
|October 7, 1997
PubMed

Insights

The retinoblastoma protein (RB) regulates cell growth by binding to other proteins. Specific phosphorylation sites on RB control these binding activities, allowing for the creation of a continuous growth suppressor.

Area of Science:

  • Molecular Biology
  • Cell Cycle Regulation
  • Cancer Biology

Background:

  • The retinoblastoma protein (RB) is a crucial tumor suppressor that controls cell cycle progression.
  • RB's growth-suppressive function relies on its ability to bind various proteins, including LXCXE motif-containing proteins, c-Abl, and E2F transcription factors.
  • Cyclin-dependent protein kinases (CDKs) phosphorylate RB, inhibiting its protein-binding activities and thus its tumor-suppressive function.

Purpose of the Study:

  • To investigate the mechanisms by which RB phosphorylation regulates E2F transcription factor binding.
  • To identify specific phosphorylation sites and their roles in modulating RB's distinct protein-binding functions.
  • To determine if a constitutively active RB growth suppressor can be generated by mutating key phosphorylation sites.

Main Methods:

  • Analysis of RB phosphorylation sites, including C-terminal and insert domain serines.
  • Construction and characterization of RB mutant proteins lacking specific phosphorylation sites.
  • Assessment of RB mutant protein binding activity to LXCXE proteins, c-Abl, and E2F.
  • Evaluation of the cell cycle arrest function of RB mutants in Rat-1 cells.

Main Results:

  • RB's E2F binding activity is inhibited by phosphorylation at distinct C-terminal sites and two insert domain serine sites.
  • Inhibition of E2F binding by insert domain phosphorylation requires the RB N-terminal region.
  • RB mutants lacking key C-terminal and insert domain phosphorylation sites retain binding to LXCXE proteins, c-Abl, and E2F, and can induce G1 cell cycle arrest.

Conclusions:

  • Multiple phosphorylation sites regulate RB's protein binding activities through distinct mechanisms.
  • Combined mutation of critical RB phosphorylation sites can generate a constitutively active growth suppressor.
  • Understanding these regulatory mechanisms is vital for developing targeted cancer therapies.

More Related Videos

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors10:33

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on: October 26, 2015

Identification of Cyclin-dependent Kinase 1 Specific Phosphorylation Sites by an In Vitro Kinase Assay12:26

Identification of Cyclin-dependent Kinase 1 Specific Phosphorylation Sites by an In Vitro Kinase Assay

Published on: May 3, 2018

Related Concept Videos

Positive Regulator Molecules01:45

Positive Regulator Molecules

To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...